Skip to main content
Premium Trial:

Request an Annual Quote

Tm Bioscience's Losses Mount But Revenues Gain as Firm Considers Strategic Options

NEW YORK (GenomeWeb News) — Tm Bioscience today said third-quarter revenues increased 19 percent as R&D spending rose 98 percent and loss increased 83 percent.
 
Total receipts for the three months ended Sept. 30 increased to $2.6 million from $2.2 million year over year.
 
Tm said $2.3 million of its sales came from its Tag-It reagents, and $300,000 came from instrument sales, an increase of 50 percent from a year ago.  
 
R&D spending increased to $1.3 million from $662,000 year over year.
 
The company said loss increased to $5.6 million from $3.1 million in the year-ago period.
 
Tm said it had around $4.7 million in cash and equivalents and $35,000 in short-term investments as of Sept. 30.
 
Earlier this week, Tm said it had formed a committee to consider merger or acquisition opportunities. In its financial statement Tm said it “continues to explore other sources of capital but believes that a strategic transaction provides the most cost effective source at this time,” but added that “no decision has been made to enter into any transaction at this time.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.